ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 772 • 2017 ACR/ARHP Annual Meeting

    Molecular Mechanism for the Therapeutic Effect of Extracorporeal Shock Wave Therapy on Digital Ulcers of Systemic Sclerosis

    Yukiko Kamogawa1, Hiroshi Fujii1, Tsuyoshi Shirai1, Tomonori Ishii2 and Hideo Harigae1, 1Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan, 2Clinical Research, Innovation and Education Center, Tohoku University Hospital, Sendai, Japan

    Background/Purpose: Digital ulcers (DUs) are the most common skin manifestations in systemic sclerosis (SSc). DUs in SSc are not usually caused by vasculitis and are…
  • Abstract Number: 773 • 2017 ACR/ARHP Annual Meeting

    The Immunophenotyping of Peripheral Blood Associates with Nailfold Microvascular Changes in Patients with Systemic Sclerosis

    Satoshi Kubo1, Shingo Nakayamada2, Maiko Yoshikawa1, Yusuke Miyazaki1, Hiroko Yoshinari3, Yurie Satoh3, Yasuyuki Todoroki3, Kazuhisa Nakano2, Shigeru Iwata4, Kentaro Hanami1, Shunsuke Fukuyo3, Ippei Miyagawa5, Minoru Satoh6 and Yoshiya Tanaka7, 1The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 2First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 3University of Occupational and Environmental Health, Japan, Fukuoka, Japan, 4First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 5University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 6Department of Clinical Nursing, School of Health Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan, 7The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan

    The immunophenotyping of peripheral blood associates with nailfold microvascular changes in patients with systemic sclerosisBackground/Purpose: Systemic sclerosis (SSc) is a complex disease with autoimmunity and…
  • Abstract Number: 774 • 2017 ACR/ARHP Annual Meeting

    The αV Integrin Inhibitor Abituzumab Inhibits Myofibroblast Differentiation

    Eileen Samy1, Yin Wu1, Georgianna Higginbotham2, Roland Grenningloh2 and Daigen Xu2, 1TIP Immunology, EMD Serono Research & Development Institute, Inc. (a business of Merck KGaA, Darmstadt, Germany), Billerica, MA, 2EMD Serono Research & Development Institute, Inc. (a business of Merck KGaA, Darmstadt, Germany), Billerica, MA

    Background/Purpose: Scleroderma is a progressive fibrotic multi-organ disease characterized by the hardening and tightening of the skin and connective tissues. TGF-β1 is a potent mediator…
  • Abstract Number: 775 • 2017 ACR/ARHP Annual Meeting

    Transcriptome Sequencing Reveals Genetic Polymorphisms Associated with Ssc Gene Expression Subtypes

    Guoshuai Cai1, Bhaven K. Mehta2, Mengqi Huang2, Jennifer Franks1, Tammara A. Wood1, Kathleen D. Kolstad3, Marianna Stark4, Antonia Valenzuela5, David Fiorentino6, Robert W. Simms7, Nicole Orzechowski8, Lorinda Chung9 and Michael L. Whitfield2, 1Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 2Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 3Rheumatology, Stanford University Medical Center, Stanford, CA, 4Stanford University, Stanford, CA, 5Immunology and Rheumatology, Stanford University, Palo Alto, CA, 6Department of Dermatology, Stanford University School of Medicine, Palo Alto, CA, 7Rheumatology, Boston University School of Medicine, Boston, MA, 8Dartmouth-Hitchcock Medical Center, Lebanon, NH, 9Rheumatology, Stanford University Medical Center, Palo Alto, CA

    Background/Purpose: Systemic sclerosis (SSc) is a complex disease characterized by substantial genotypic and phenotypic heterogeneity. Four molecular gene expression subsets have been identified from SSc…
  • Abstract Number: 776 • 2017 ACR/ARHP Annual Meeting

    Circulating Fibrocytes in Systemic Sclerosis Patients and Healthy Subjects: An in Vitro Study

    Maurizio Cutolo1, Paola Montagna2, Stefano Soldano2, Amelia Chiara Trombetta3, Paola Contini4, Vanessa Smith5, Barbara Ruaro2, Alberto Sulli3 and Renata Brizzolara2, 1Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, IRCCS A.O.U. San Martino-IST, University of Genova, Genoa, Italy, Genoa, Italy, 2Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino, Genoa, Italy, Genoa, Italy, 3Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, IRCCS A.O.U. San Martino-IST, University of Genova, Genoa, Italy, Genova, Italy, 4Division of Clinical Immunology, Department of Internal Medicine, University of Genova, Genoa, Italy, Genova, Italy, 5Faculty of Internal Medicine, Ghent University, Ghent, Belgium

    Background/Purpose: Circulating fibrocytes seem to exert immunomodulatory effects, expressing class II major histocompatability complex molecules (HLA-DP, -DQ, and -DR) and could have a role in…
  • Abstract Number: 777 • 2017 ACR/ARHP Annual Meeting

    Differences between Temporal Artery Biopsy-Positive and Biopsy-Negative Giant Cell Arteritis: A Comparative Cohort Study

    Matthew J. Koster1, Karthik Yeruva1, Cynthia S. Crowson2 and Kenneth J. Warrington1, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN

    Background/Purpose: Giant cell arteritis (GCA) is the most common systemic vasculitis in patients aged 50 years or older. The presence of cranial features and an…
  • Abstract Number: 778 • 2017 ACR/ARHP Annual Meeting

    Safety Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations

    Sara Gale1, Sophie Dimonaco2, Huong Trinh1, Katie Tuckwell2, Neil Collinson2, John H. Stone3, Khaled Sarsour1, Jinglan Pei4, Jennifer H. Best1, Christine Birchwood4 and Shalini Mohan1, 1Genentech, South San Francisco, CA, 2Roche Products, Ltd., Welwyn Garden City, United Kingdom, 3Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA, 4Genentech, Inc., South San Francisco, CA

    Background/Purpose: Recent clinical trial findings have shown efficacy for tocilizumab (TCZ) in treating giant cell arteritis (GCA).1,2 TCZ was approved for the treatment of GCA…
  • Abstract Number: 779 • 2017 ACR/ARHP Annual Meeting

    Assessment of Treatment Response By 18f-Fludeoxyglucose Positron Emission Tomography (FDG-PET) in Patients with Large Vessel Vasculitis (LVV)

    Shubhasree Banerjee1, Sara Alehashemi2, Ali Cahid Civelek3, Elaine Novakovich4, Armin Bagheri5, Ashkan Malayeri3, Mark Ahlman3 and Peter C. Grayson6, 1Fellowship and training branch, NIAMS/NIH, Bethesda, MD, 2Rheumatology, National Institutes of Health, Bethesda, MD, 3Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD, 4Systemic Autoimmunity Branch, NIAMS, National Institutes of Health, Bethesda, MD, 5Vasculitis Translational Research Program, NIAMS, NIH, Bethesda, MD, 6Research, National Institutes of Health, Bethesda, MD

    Background/Purpose: Disease activity in large vessel vasculitis (LVV) is traditionally assessed by clinical and serological (ESR, CRP) parameters. Imaging assessment, including FDG-PET, may also be…
  • Abstract Number: 780 • 2017 ACR/ARHP Annual Meeting

    Short and Long-Term Follow-up with Tocilizumab in Giant Cell Arteritis. National Multicenter Study of 49 Patients of Clinical Practice

    Lucia C. Domínguez-Casas1, Javier Loricera1, Jose L. Hernández2, Santos Castañeda3, Vicente Aldasoro4, María Varela-García5, Rosario Ibañez-Bosch5, Antonio Mera6, Eva Pérez-Pampin6, Alicia Humbría7, Jaime Calvo-Alén8, Elena Aurrecoechea9, Javier Narváez10, Amalia Sánchez-Andrade11, Paloma Vela12, Elvira Diez Alvarez13, Clara Moriano14, Cristina Mata15, Pau Lluch16, Concepción Moll17, Íñigo Hernández-Rodríguez18, Vanesa Calvo-Río1, José Andrés Román-Ivorra19, Carlos Vazquez20, Alfonso Corrales1, MC Gonzalez-Vela21, Francisco Ortiz-Sanjuán22, Belén Atienza-Mateo1, José Luis Martín-Varillas1, Miguel Angel González-Gay23 and Ricardo Blanco1, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 2Internal Medicine, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 3Hospital Universitario La Princesa. IIS-IP. Madrid. Spain, Madrid, Spain, 4Hospital Alto Deba. Mondragón. Spain, Mondragon, Spain, 5Rheumatology, Complejo Hospitalario de Navarra. Navarra. Spain, Navarra, Spain, 6Rheumatology, Complejo Hospitalario Universitario de Santiago. Galicia. Spain, Santiago de Compostela, Spain, 7Rheumatology, Hospital Universitario La Princesa. IIS-IP. Madrid. Spain, Madrid, Spain, 8Rheumatology, Hospital de Sierrallana. Torrelavega. Cantabria. Spain, Alava, Spain, 9Rheumatology, Hospital de Sierrallana, Torrelavega. Cantabria. Spain, Torrelavega, Spain, 10Rheumatology Department, Hospital de Bellvitge. Barcelona. Spain, L’Hospitalet de Llobregat, Spain, 11Hospital Universitario Lucus Augusti. Lugo. Spain, Lugo, Spain, 12Reumatología, Hospital General Universitario de Alicante. Alicante. Spain, Alicante, Spain, 13Complejo Asistencial Universitario de León. León. Spain, León, Spain, 14Rheumatology, Complejo Asistencial Universitario de León. León. Spain, Leon, Spain, 15Rheumatology, Hospital de Laredo. Laredo. Spain, Laredo, Spain, 16Rheumatology, Hospital Mateu Orfila. Menorca. Spain, Menorca, Spain, 17Rheumatology., Hospital Mateu Orfila. Menorca. Spain, Menorca, Spain, 18Rheumatology, CHUVI Vigo. Galicia. Spain, Vigo, Spain, 19Rheumatology, Hospital Universitario La Fe. Valencia. Spain, Valencia, Spain, 20Rheumatology, Hospital Miguel Servet. Zaragoza. Spain, Zaragoza, Spain, 21Pathology Anatomy, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 22Rheumatology., Hospital Universitario La Fe. Valencia. Spain, Valencia, Spain, 23Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Johannesburg, South Africa

    Background/Purpose: Randomized clinical trial has shown the efficacy of tocilizumab (TCZ) in Giant cell arteritis (GCA). However this data are of selected cases of clinical…
  • Abstract Number: 781 • 2017 ACR/ARHP Annual Meeting

    A Patient Based Reliability Exercise of Omeract Ultrasound Definitions in Giant Cell Arteritis

    Valentin S. Schäfer1, Stavros Chrysidis2, Christian Dejaco3, Christina Duftner4, Annamaria Iagnocco5, George A. W. Bruyn6, Greta Carrara7, MA D'Agostino8, Eugenio De Miguel9, Andreas P Diamantopoulos10, Ulrich Fredberg11, Wolfgang Hartung12, Alojzija Hočevar13, Tanaz A. Kermani14, Matthew J. Koster15, Tove Lorenzen16, Pierluigi Macchioni17, Marcin Milchert18, Uffe Møller Døhn19, Chetan Mukhtyar20, Cristina Ponte21, Sofia Ramiro22, Carlo Alberto Scirè23, Lene Terslev24, Kenneth J. Warrington15, Bhaskar Dasgupta25 and Wolfgang A. Schmidt26, 1Immanuel Krankenhaus Berlin, Medical Center for Rheumatology Berlin-Buch, Berlin, Germany, 2Department of Rheumatology, Hospital of Southwest Denmark, Esbjerg, Denmark, 3Rheumatology and Immunology, Medical University Graz, Graz, Austria, 4Department of Internal Medicine, Clinical Division of Internal Medicine II, Medical University Innsbruck, Innsbruck, Austria, 5Academic Rheumatology Unit, Università degli Studi di Torino, Torino, Italy, 6Rheumatology, MC Groep, Loenga, Netherlands, 7Epidemiology Unit, Italian Society for Rheumatology, Milano, Italy, 8Rheumatology, Versailles-Saint Quentin en Yvelines University, Boulogne-Billancourt, France, 9Medicine, Universidad Autonoma Madrid, MADRID, Spain, 10Martina Hansens Hospital, Bærum, Oslo, Norway, 11Diagnostic Centre, Silkeborg Regional Hospital, 8600 Silkeborg, Denmark, 12Department of Rheumatology/Clinical Immunology, Asklepios Medical Center, 93077 Bad Abbach, Germany, 13Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, 14Rheumatology, University of California Los Angeles, Los Angeles, CA, 15Rheumatology, Mayo Clinic, Rochester, MN, 16Diagnostic Centre, Region Hospital Silkeborg, Silkeborg, Denmark, 17Arcispedale Santa Maria Nuova, Reggio Emilia, Italy, 18Pomeranian Medical University, Szczecin,, Szczecin, Poland, 19Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Copenhagen Center for Arthritis Research (COPECARE), Glostrup, Denmark, 20Norfolk and Norwich University Hospital, Norwich, United Kingdom, 21Rheumatology Department, Hospital de Santa Maria - Centro Hospital Lisboa Norte, Lisbon, Portugal, 22Rheumatology, Department of Rheumatology, LUMC, Leiden, Netherlands, Leiden, Netherlands, 23Italian Society for Rheumatology, Milan, Italy, 24Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Denmark, Copenhagen, Denmark, 25Rheumatology, Southend University Hospital NHS Foundation Trust, Southend, UK, Westcliff-on-Sea, United Kingdom, 26Medical Center for Rheumatology and Clinical Immunology Berlin-Buch, Immanuel Krankenhaus Berlin, Berlin, Germany

    Background/Purpose: To test the reliability of recently established consensus-based ultrasound definitions for normal and vasculitic temporal and axillary arteries in patients with giant cell arteritis…
  • Abstract Number: 782 • 2017 ACR/ARHP Annual Meeting

    Serum IL-6, SAA and Calprotectin As Biomarkers in Giant Cell Arteritis and Polymyalgia Rheumatica

    Yannick van Sleen, Marjolein Hoekstra, Johan Bijzet, Wayel H. Abdulahad, Annemieke M.H. Boots and Elisabeth Brouwer, Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose: GCA and PMR are closely related inflammatory diseases. The diagnostic criteria of both disorders depend on a combination of clinical features and elevated ESR…
  • Abstract Number: 783 • 2017 ACR/ARHP Annual Meeting

    European League Against Rheumatisms Recommendations for the Use of Imaging in Large Vessel Vasculitis in Clinical Practice

    Christian Dejaco1, Sofia Ramiro2, Christina Duftner3, Florent L. Besson4, Thorsten Bley5, Daniel Blockmans6, Elisabeth Brouwer7, Marco A. Cimmino8, Eric Clark9, Bhaskar Dasgupta10, Andreas P Diamantopoulos11, Haner Direskeneli12, Annamaria Iagnocco13, Thorsten Klink5, Lorna Neill14, Cristina Ponte15, Carlo Salvarani16, Riemer Slart17, Madeline Whitlock18 and Wolfgang A. Schmidt19, 1Rheumatology, Hospital of Bruneck, Bruneck, Italy, 2Rheumatology, Department of Rheumatology, LUMC, Leiden, Netherlands, Leiden, Netherlands, 3Department of Internal Medicine, Clinical Division of Internal Medicine II, Medical University Innsbruck, Innsbruck, Austria, 4Department of Nuclear Medicine, CHU Bicêtre, AP-HP, Université Paris-Sud, Paris, France, 5University of Würzburg, Würzburg, Germany, 6General Internal Medicine, University Hospital Gasthuisberg, Leuven, Belgium, 7Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 8Research Laboratory and Academic Unit of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genova, Italy, 9PMRGCAuk, London, United Kingdom, 10Rheumatology, Southend University Hospital NHS Foundation Trust, Southend, UK, Westcliff-on-Sea, United Kingdom, 11Rheumatology, Martina Hansens Hospital, Bærum, Oslo, Norway, 12Departement of İnternal Medicine, Division of Rheumatology, Marmara University, Istanbul, Turkey, 13Academic Rheumatology Unit, Università degli Studi di Torino, Torino, Italy, 14PMRGCAuk, Dundee, United Kingdom, 15Instituto de Medicina Molecular (IMM), Rheumatology Research Unit, Lisbon, Portugal, 16Rheumatology Unit, Arcispedale Santa Maria Nuova - IRCCS; Università di Modena e Reggio Emilia, Reggio-Emilia, Italy, 17University of Groningen, Enschede, Netherlands, 18Southend University Hospital, Southend, United Kingdom, 19Medical Center for Rheumatology and Clinical Immunology Berlin-Buch, Immanuel Krankenhaus Berlin, Berlin, Germany

    Background/Purpose: Modern imaging modalities including ultrasound, magnetic resonance imaging (MRI), computed tomography (CT) and 18F-FDG positron emission tomography (PET/CT) have been increasingly used in primary…
  • Abstract Number: 784 • 2017 ACR/ARHP Annual Meeting

    Damage and Predictors of Damage in Takayasu’s Arteritis

    Antoine G. Sreih1, Tanaz A. Kermani2, David Cuthbertson3, Simon Carette4, Nader A. Khalidi5, Curry L. Koening6, Carol A. Langford7, Carol A. McAlear8, Paul A. Monach9, Larry W. Moreland10, Christian Pagnoux11, Philip Seo12, Kenneth J. Warrington13, Steven R. Ytterberg13 and Peter A. Merkel1,14, 1Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Division of Rheumatology, University of California, Los Angeles, CA, 3Biostatistics and Informatics, Department of Pediatrics, University of South Florida, Tampa, FL, 4Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 5Rheumatology, McMaster University, Hamilton, ON, Canada, 6Rheumatology, University of Utah, Salt Lake City, UT, 7Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, 8University of Pennsylvania, Philadelphia, PA, 9Boston University School of Medicine, Boston, MA, 10Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 11Rheumatology-Vasculitis clinic, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 12Medicine, Johns Hopkins University, Baltimore, MD, 13Rheumatology, Mayo Clinic, Rochester, MN, 14Biostatistics, Epidemiology, and Bioinformatics, University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Information regarding the degree and the predictors of damage in patients with Takayasu’s arteritis (TAK) is limited. This study aimed to characterize damage and…
  • Abstract Number: 785 • 2017 ACR/ARHP Annual Meeting

    Longitudinal Angiographic Findings in Patients with Takayasu’s Arteritis

    Antoine G. Sreih1, Tanaz A. Kermani2, David Cuthbertson3, Simon Carette4, Lindsy J. Forbess5, Nader A. Khalidi6, Curry L. Koening7, Carol A. McAlear8, Paul A. Monach9, Larry W. Moreland10, Christian Pagnoux11, Philip Seo12, Robert F. Spiera13, Kenneth J. Warrington14, Steven R. Ytterberg14, Carol A. Langford15 and Peter A. Merkel16,17, 1Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Division of Rheumatology, University of California, Los Angeles, CA, 3Biostatistics and Informatics, Department of Pediatrics, University of South Florida, Tampa, FL, 4Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 5Medicine, Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 6Rheumatology, McMaster University, Hamilton, ON, Canada, 7Rheumatology, University of Utah, Salt Lake City, UT, 8University of Pennsylvania, Philadelphia, PA, 9Boston University School of Medicine, Boston, MA, 10Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 11Rheumatology-Vasculitis clinic, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 12Medicine, Johns Hopkins University, Baltimore, MD, 13Rheumatology, Hospital for Special Surgery, New York, NY, 14Rheumatology, Mayo Clinic, Rochester, MN, 15Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, 16Biostatistics, Epidemiology, and Bioinformatics, University of Pennsylvania, Philadelphia, PA, 17Division of Rheumatology, University of Pennsylvania, Philadelphia, PA

    Background/Purpose : Longitudinal data on the type, progression, and predictors of arterial lesions in patients with Takayasu’s arteritis (TAK) is limited. This study aimed to…
  • Abstract Number: 786 • 2017 ACR/ARHP Annual Meeting

    Smoking As a Risk Factor for Giant Cell Arteritis: A Systematic Review and Meta-Analysis

    David Brennan1, Patompong Ungprasert2, Kenneth J. Warrington2 and Matthew J. Koster2, 1Internal Medicine, Mayo Clinic, Rochester, MN, 2Rheumatology, Mayo Clinic, Rochester, MN

    Background/Purpose: Tobacco smoking is a well-established risk factor for the development of several autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus.  A similar…
  • « Previous Page
  • 1
  • …
  • 1255
  • 1256
  • 1257
  • 1258
  • 1259
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology